Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBRENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBRENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBRNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DJ.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DJ.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DJ.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DJ.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.21ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AZ.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AZ.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AZ.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.193ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.193ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.193ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.193NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BL.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BL.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FP.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FP.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FP.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FP.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DA.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DA.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.68 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.68 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.68 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.68 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.16.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.16.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.16.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.16.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DN.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DN.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used